Jain Global LLC Denali Therapeutics Inc. Transaction History
Jain Global LLC
- $11.9 Billion
- Q2 2025
A detailed history of Jain Global LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Jain Global LLC holds 14,486 shares of DNLI stock, worth $216,131. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,486Holding current value
$216,131% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DNLI
# of Institutions
253Shares Held
135MCall Options Held
148KPut Options Held
15.4K-
Black Rock Inc. New York, NY13.2MShares$197 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$176 Million0.0% of portfolio
-
Baillie Gifford & CO11.6MShares$173 Million0.13% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.58MShares$98.2 Million0.01% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL6.26MShares$93.4 Million0.02% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $2B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...